Lonza buys InterHealth Nutraceuticals for up to €267m

- Last updated on GMT

©iStock
©iStock

Related tags: Nutrition, Medicine, Management, Lonza

Swiss ingredients and pharma giant Lonza has agreed to pay up to $300 million (€267m) for Californian nutrient specialist InterHealth Nutraceuticals.

Lonza gains a suite of about 15 branded nutrients including its marquee collagen offering, UC-II.

“We are looking forward to welcoming the highly capable team to our Lonza family,”​ said Lonza CEO Richard Ridinger in a statement.

“They nicely complement our offerings and will be joining us in our quest to becoming the world’s leading and most-trusted supplier to the pharmaceutical, biotech and specialty ingredients markets. Lonza will be able to harness the proven management and branding capabilities and leverage them to a global level.”

The payment is split between an up-front payment and an earn-out payment.

Lonza said InterHealth – formerly owned by Kainos Capital - would continue to operate in the same premises with the same staff.

Otgher InterHealth offering include Meratrim for weight management; Relora for stress management; ChromeMate and Zychrome for blood sugar and insulin control and CardiaSlim for  cholesterol management.

Related news

Show more

Related products

show more

Stronger Bones Begin with MenaQ7® Vitamin K2

Stronger Bones Begin with MenaQ7® Vitamin K2

Gnosis by Lesaffre | 06-Jun-2022 | Infographic

By activating the K-dependent protein Osteocalcin, Vitamin K2 as MK-7 enables the body to properly utilize calcium, binding it to the bone matrix.

Botanicals you can rely on, from ADM

Botanicals you can rely on, from ADM

ADM | 02-Jun-2022 | Product Brochure

Today more than ever, consumers are striving to support their overall well-being in a convenient way, with foods, beverages and dietary supplements that...

Related suppliers

Follow us

Products

View more

Webinars